Trial intelligence / Profile preview

Rosuvastatin for Atherosclerosis in Rheumatoid Arthritis

NCT00555230Phase 2Completed

Sponsor
The Chinese University of Hong Kong
Start
Jul 2007
Primary completion
Dec 2009
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of rosuvastatin in atherosclerosis, sponsored by The Chinese University of Hong Kong. Started Jul 2007; status: completed.

02

Drugs

rosuvastatin
03

Conditions

atherosclerosis

Beyond the preview

Go deeper on NCT00555230.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00555230.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call